The Distribution of Cardiac Output in the Anaesthetized Spontaneously Hypertensive Rat

Autor: Yates Ms, Hilley Cr

Publikováno v: Clinical Science. 55:317-320

1. Radioactive 15 μm and 50 μm diameter microspheres were used to determine cardiac output, its regional distribution and tissue blood flow in adult normotensive Wistar and Okamoto spontaneously hypertensive rats. 2. Cardiac output in the spontaneo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4282de85dd97c4fe926fcff058f8d8f
https://doi.org/10.1042/cs0550317

Uterine-Conserving Treatment Options for Atypical Endometrial Hyperplasia and Early Endometrial Cancer.

Autor: Adjei NN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1155 Herman Pressler Boulevard, Unit 1362, Houston, TX 77030, CPB6.3279, USA., Bowen MB; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1155 Herman Pressler Boulevard, Unit 1362, Houston, TX 77030, CPB6.3279, USA., Wilke RN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1155 Herman Pressler Boulevard, Unit 1362, Houston, TX 77030, CPB6.3279, USA., Yates MS; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1155 Herman Pressler Boulevard, Unit 1362, Houston, TX 77030, CPB6.3279, USA. swestin@mdanderson.org.

Publikováno v: Current oncology reports [Curr Oncol Rep] 2024 Nov; Vol. 26 (11), pp. 1367-1379. Date of Electronic Publication: 2024 Oct 03.

The influence of interactions with pet dogs on psychological distress.

Autor: Matijczak A; Department of Psychology, Yale University., Yates MS; Department of Psychology, University of California, Santa Cruz., Ruiz MC; Department of Psychology, Yale University., Santos LR; Department of Psychology, Yale University., Kazdin AE; Department of Psychology, Yale University., Raila H; Department of Psychology, University of California, Santa Cruz.

Publikováno v: Emotion (Washington, D.C.) [Emotion] 2024 Mar; Vol. 24 (2), pp. 384-396. Date of Electronic Publication: 2023 Aug 10.

Obesity is associated with improved progression-free survival in Microsatellite-Instability-High endometrial cancer treated with pembrolizumab.

Autor: Bernard L; Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, Unit 1362, PO Box 301439, Houston, TX 77230-1439, USA. Electronic address: laurence.bernard2@mcgill.ca., How JA; Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, Unit 1362, PO Box 301439, Houston, TX 77230-1439, USA., Patel S; Clinical Pharmacy Programs, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 90, Houston, TX 77030-4009, USA., Yates MS; Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, Unit 1362, PO Box 301439, Houston, TX 77230-1439, USA., Jazaeri A; Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, Unit 1362, PO Box 301439, Houston, TX 77230-1439, USA.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2024 Jan; Vol. 180, pp. 139-145. Date of Electronic Publication: 2023 Dec 12.

Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.

Autor: Vellano CP; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., White MG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Andrews MC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Medicine, Central Clinical School, Monash University, Melbourne, Victoria, Australia., Chelvanambi M; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Witt RG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daniele JR; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Titus M; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Conforti F; Division of Melanoma, Sarcoma, and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy., Burton EM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lastrapes MJ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ologun G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Surgery, Guthrie Courtland Medical Center, Courtland, NY, USA., Cogdill AP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Immunai, New York, NY, USA., Morad G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Prieto P; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Surgery, University of Rochester, Rochester, NY, USA., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chu Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Han G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khan MAW; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Helmink B; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Surgery, Washington University in St Louis, St Louis, MO, USA., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kovacs JJ; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Woodman SE; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patel S; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Moffitt Cancer Center, Tampa, FL, USA., Peoples M; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cooper ZA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; AstraZeneca, Gaithersburg, MD, USA., Zhu H; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gao G; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Banerjee H; Clinical Development and Analytics, Novartis Pharmaceuticals, East Hanover, NJ, USA., Lau M; Novartis Pharma, Basel, Switzerland., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lucci A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Keung EZ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pala L; Division of Melanoma, Sarcoma, and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy., Pagan E; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy., Segura RL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu Q; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Borthwick MS; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lau E; Department of Tumor Biology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Yates MS; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wani K; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tetzlaff MT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, University of California, San Francisco, CA, USA., Haydu LE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mahendra M; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ma X; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Logothetis C; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kulstad Z; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Johnson S; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hudgens CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Feng N; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Federico L; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Long GV; Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Arur S; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Moran AE; Cell, Development & Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Heffernan TP; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. TPHeffernan@mdanderson.org., Marszalek JR; TRACTION Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jrmarszalek@mdanderson.org., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.

Publikováno v: Nature [Nature] 2023 Jan; Vol. 613 (7945), pp. E3.